Lee's Pharmaceutical Holdings Limited provided earnings guidance for the six months ended 30 June 2023. For the period, the Group is expected to record an unaudited net profit attributable to the Shareholders of between HKD 12 million and HKD 17 million for the six months ended 30 June 2023 as compared with approximately HKD 28 million recorded for the six months ended 30 June 2022.